Target intelligence / Profile preview

Protein transport protein Sec23A (SEC23A)

Target
SEC23A
Molecular classification
Transporter, COPII component, Protein coat complex subunit
01

Overview

Protein transport protein Sec23A (SEC23A) is a core component of the coat protein complex II (COPII) that facilitates the formation of transport vesicles from the endoplasmic reticulum (ER), enabling the trafficking of newly synthesized proteins and lipids to the Golgi apparatus for secretion or further modification[3][1]. SEC23A acts as a GTPase-activating protein within the COPII inner coat, working in complex with SEC24 and interacting with other coat subunits such as SAR1 and SEC31[1][3]. The protein plays critical roles in the selection of cargo for ER exit, and its function is tightly linked to general secretion processes and autophagy pathways, including regulation by phosphorylation events[1]. Mutations in SEC23A are associated with cranio-lenticulo-sutural dysplasia and other congenital disorders, and its dysregulation is implicated in cancer—where low SEC23A levels are linked to poorer clinical outcomes[1][3]. SEC23A is indispensable for embryonic development and secretory tissue viability, highlighting its therapeutic and pathological relevance[1].

Other names
SEC23AhSec23ASEC23 homolog ACOPII coat complex componentSec23 homolog ACLSDprotein transport protein Sec23ASEC23-related protein A
02

Biological functions

ER-to-Golgi protein traffickingVesicle formationCargo selectionAutophagy regulationProtein secretionLipid transportCell proliferationEmbryonic development
03

Disease associations

Cranio-lenticulo-sutural dysplasiaCancerCongenital disorder of glycosylationOther developmental disorders
04

Safety considerations

Essential for embryonic development—loss causes embryonic lethality in miceLoss of function can induce ER stress and apoptosis in secretory tissuesPotential effects on multiple organ systems due to fundamental role in secretion
05

Biomarkers

Reduced SEC23A expression is associated with poor relapse-free survival in breast cancer patientsSEC23A expression levels as potential biomarker for cancer prognosis

Beyond the preview

Go deeper on Protein transport protein Sec23A (SEC23A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein transport protein Sec23A (SEC23A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call